Despite the success of its new weight loss drug Zepbound, Lilly's recent earnings failed to meet expectations.

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. All equity classes ...

Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...

Analyst David Risinger of Leerink Partners reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), retaining the price target of ...

What role did partnerships with area organizations play in securing Indiana Tech’s $21.5 million Lilly Endowment grant?

Evercore ISI analyst Umer Raffat maintained a Hold rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last ...

Indiana's Chloe Moore-McNeil (22) scores over Stanford's Tess Heal (34) during the Indiana versus Stanford women's basketball ...

Lilly will also conduct a conference call that ... the Medicine Foundry will be located in Indiana's LEAP Research More than 80 percent of adults and adolescents with moderate-to-severe atopic ...

Hoosiers’ out-of-pocket health care spending is higher than in neighboring states, and a new Indiana University analysis ...

While sophomore guard Juliana LaMendola scored just 1 point for Indiana, Moren complimented her defensive efforts against a ...